Terms: = Head and neck cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Clinical Outcome
21 results:
1. Hydroxysafflor Yellow A of Carthamus Tinctorius L., Represses the Malignant Development of Esophageal cancer Cells via Regulating NF-κB Signaling Pathway.
Chen X; Wang Y; Zhang L; Gao Y
Cell Biochem Biophys; 2020 Dec; 78(4):511-520. PubMed ID: 32705535
[TBL] [Abstract] [Full Text] [Related]
2. MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F.
Yang H; Wei YN; Zhou J; Hao TT; Liu XL
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3200-3206. PubMed ID: 28770965
[TBL] [Abstract] [Full Text] [Related]
3. miR-183 and miR-21 expression as biomarkers of progression and survival in tongue carcinoma patients.
Supic G; Zeljic K; Rankov AD; Kozomara R; Nikolic A; Radojkovic D; Magic Z
Clin Oral Investig; 2018 Jan; 22(1):401-409. PubMed ID: 28616749
[TBL] [Abstract] [Full Text] [Related]
4. TERT promoter mutations in sinonasal malignant melanoma: a study of 49 cases.
Jangard M; Zebary A; Ragnarsson-Olding B; Hansson J
Melanoma Res; 2015 Jun; 25(3):185-8. PubMed ID: 25746036
[TBL] [Abstract] [Full Text] [Related]
5. Epithelial-mesenchymal transition in human papillomavirus-positive and -negative oropharyngeal squamous cell carcinoma.
Hatakeyama H; Mizumachi T; Sakashita T; Kano S; Homma A; Fukuda S
Oncol Rep; 2014 Dec; 32(6):2673-9. PubMed ID: 25241968
[TBL] [Abstract] [Full Text] [Related]
6. Imaging and clinicopathologic features of esophageal gastrointestinal stromal tumors.
Winant AJ; Gollub MJ; Shia J; Antonescu C; Bains MS; Levine MS
AJR Am J Roentgenol; 2014 Aug; 203(2):306-14. PubMed ID: 25055264
[TBL] [Abstract] [Full Text] [Related]
7. Combination antiangiogenic therapy and radiation in head and neck cancers.
Hsu HW; Wall NR; Hsueh CT; Kim S; Ferris RL; Chen CS; Mirshahidi S
Oral Oncol; 2014 Jan; 50(1):19-26. PubMed ID: 24269532
[TBL] [Abstract] [Full Text] [Related]
8. cd117 expression in operable oesophageal squamous cell carcinomas predicts worse clinical outcome.
Fan H; Yuan Y; Wang J; Zhou F; Zhang M; Giercksky KE; Nesland JM; Suo Z
Histopathology; 2013 Jun; 62(7):1028-37. PubMed ID: 23570416
[TBL] [Abstract] [Full Text] [Related]
9. Establishment and characterization of a novel xenograft model of human gastrointestinal stromal tumor in mice.
Moriyama M; Shimada Y; Nagata T; Omura T; Sekine S; Matsui K; Yoshioka I; Okumura T; Sawada S; Yoshida T; Tsukada K
Anticancer Res; 2013 Jan; 33(1):175-81. PubMed ID: 23267143
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological and molecular aspects of foregut gastrointestinal stromal tumours.
Chen J; Gundara JS; Haddad R; Schiavone V; Meldrum C; Samra JS; Gill AJ; Hugh TJ
ANZ J Surg; 2014; 84(1-2):52-8. PubMed ID: 23171083
[TBL] [Abstract] [Full Text] [Related]
11. Expression of the proliferation marker Ki-67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomas.
Müssig K; Wehrmann T; Dittmann H; Wehrmann M; Ueberberg B; Schulz S; Bares R; Petersenn S
Clin Endocrinol (Oxf); 2012 Jul; 77(1):139-45. PubMed ID: 22248072
[TBL] [Abstract] [Full Text] [Related]
12. Chemotherapeutic alteration of β-catenin and c-kit expression by imatinib in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.
Schultz JD; Sommer JU; Hoedt S; Erben P; Hofheinz RD; Faber A; Thorn C; Hörmann K; Sauter A
Oncol Rep; 2012 Jan; 27(1):270-80. PubMed ID: 21993766
[TBL] [Abstract] [Full Text] [Related]
13. Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors.
Papaspyrou G; Garbe C; Schadendorf D; Werner JA; Hauschild A; Egberts F
Melanoma Res; 2011 Dec; 21(6):475-82. PubMed ID: 21897303
[TBL] [Abstract] [Full Text] [Related]
14. Morphological heterogeneity of oral salivary gland carcinomas: a clinicopathologic study of 41 cases with long term follow-up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma.
Schwarz S; Müller M; Ettl T; Stockmann P; Zenk J; Agaimy A
Int J Clin Exp Pathol; 2011 Apr; 4(4):336-48. PubMed ID: 21577319
[TBL] [Abstract] [Full Text] [Related]
15. Motesanib diphosphate in progressive differentiated thyroid cancer.
Sherman SI; Wirth LJ; Droz JP; Hofmann M; Bastholt L; Martins RG; Licitra L; Eschenberg MJ; Sun YN; Juan T; Stepan DE; Schlumberger MJ;
N Engl J Med; 2008 Jul; 359(1):31-42. PubMed ID: 18596272
[TBL] [Abstract] [Full Text] [Related]
16. Primary glomangioma of the esophagus mimicking esophageal papilloma.
Tomas D; Tomić K; Bekavac-Beslin M; Jukić Z; Belicza M; Kruslin B
Dis Esophagus; 2006; 19(3):208-11. PubMed ID: 16723001
[TBL] [Abstract] [Full Text] [Related]
17. Ceruminous adenomas: a clinicopathologic study of 41 cases with a review of the literature.
Thompson LD; Nelson BL; Barnes EL
Am J Surg Pathol; 2004 Mar; 28(3):308-18. PubMed ID: 15104293
[TBL] [Abstract] [Full Text] [Related]
18. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.
Ang KK; Berkey BA; Tu X; Zhang HZ; Katz R; Hammond EH; Fu KK; Milas L
Cancer Res; 2002 Dec; 62(24):7350-6. PubMed ID: 12499279
[TBL] [Abstract] [Full Text] [Related]
19. The prognostic value of the tumour marker Cyfra 21-1 in carcinoma of head and neck and its role in early detection of recurrent disease.
Doweck I; Barak M; Uri N; Greenberg E
Br J Cancer; 2000 Dec; 83(12):1696-701. PubMed ID: 11104568
[TBL] [Abstract] [Full Text] [Related]
20. Decreased expression of Bax is correlated with poor prognosis in oral and oropharyngeal carcinoma.
Ito T; Fujieda S; Tsuzuki H; Sunaga H; Fan G; Sugimoto C; Fukuda M; Saito H
Cancer Lett; 1999 Jun; 140(1-2):81-91. PubMed ID: 10403545
[TBL] [Abstract] [Full Text] [Related]
[Next]
